Vishnumurthy Hegde
15Patents
4h-index
20Co-inventors
60Inventor score
Filing activity: May 29, 1996 → Jul 3, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8088594B2 | Risperidone immunoassay | Emerging Cross-Sectional Technologies | 36 | Active |
| US9585934B2 | Therapeutic vitamin D conjugates | Human Necessities | 7 | Active |
| US9616109B2 | Insulin vitamin D conjugates | Chemistry; Metallurgy | 6 | Active |
| US5932752A | Process for the C-C bond forming reaction using solid acid catalysts | Chemistry; Metallurgy | 6 | Expired |
| US9789197B2 | RNAi vitamin D conjugates | Human Necessities | 4 | Active |
| US10406202B2 | Therapeutic vitamin D conjugates | Human Necessities | 3 | Active |
| US11116816B2 | Therapeutic vitamin d conjugates | Human Necessities | 2 | Active |
| US10702574B2 | Therapeutic vitamin D conjugates | Human Necessities | 2 | Active |
| US10420819B2 | Insulin vitamin D conjugates | Chemistry; Metallurgy | 2 | Active |
| US8114621B2 | Lenalidomide and thalidomide immunoassays | Emerging Cross-Sectional Technologies | 1 | Active |
| US12076366B2 | Therapeutic vitamin D conjugates | Human Necessities | 0 | Active |
| US8440796B2 | Lenalidomide and thalidomide immunoassays | Emerging Cross-Sectional Technologies | 0 | Active |
| US8293492B2 | Lenalidomide and thalidomide immunoassays | Emerging Cross-Sectional Technologies | 0 | Active |
| US7524860B2 | Antibacterial agents | Human Necessities | 0 | Expired |
| US8450461B2 | Risperidone immunoassay | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.